These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 23039800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ, Tu L, Wang M, Ma XL, Yang LX, Shen YY, Zhuang C, Zhao WY, Qiu JF, Zhao G, Cao H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep 25; 23(9):872-879. PubMed ID: 32927512
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
    Buleje J, Acosta Ó, Guevara-Fujita M, Enriquez Y, Taxa L, Machicado E, Lizaraso-Caparó F, Fujita R.
    Rev Esp Enferm Dig; 2015 Feb 25; 107(2):72-8. PubMed ID: 25659388
    [Abstract] [Full Text] [Related]

  • 6. KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.
    Joensuu H, Rutkowski P, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Braconi C, Bordoni A, Magnusson MK, Sufliarsky J, Federico M, Jonasson JG, Hostein I, Bringuier PP, Emile JF.
    J Clin Oncol; 2015 Feb 20; 33(6):634-42. PubMed ID: 25605837
    [Abstract] [Full Text] [Related]

  • 7. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J, Bümming P, Meis-Kindblom JM, Sihto H, Nupponen N, Joensuu H, Odén A, Gustavsson B, Kindblom LG, Nilsson B.
    Gastroenterology; 2006 May 20; 130(6):1573-81. PubMed ID: 16697720
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.
    Oncotarget; 2016 May 24; 7(21):30109-18. PubMed ID: 27097112
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS.
    Anticancer Res; 2012 Mar 24; 32(3):923-37. PubMed ID: 22399613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, Maurel J, Calabuig S, Gutierrez A, González de Sande JL, Martínez J, De Juan A, Laínez N, Losa F, Alija V, Escudero P, Casado A, García P, Blanco R, Buesa JM, Spanish Group for Sarcoma Research.
    J Clin Oncol; 2005 Sep 01; 23(25):6190-8. PubMed ID: 16135486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S, Pasternack H, Ihle MA, Merkelbach-Bruse S, Heitkötter B, Hartmann W, Trautmann M, Gevensleben H, Büttner R, Schildhaus HU, Wardelmann E.
    Hum Pathol; 2017 Apr 01; 62():206-214. PubMed ID: 28159677
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM.
    Scand J Gastroenterol; 2013 Sep 01; 48(9):1055-65. PubMed ID: 23862765
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
    Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS.
    Clin Cancer Res; 2004 May 01; 10(9):3076-81. PubMed ID: 15131046
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.
    Chen J, Gundara JS, Haddad R, Schiavone V, Meldrum C, Samra JS, Gill AJ, Hugh TJ.
    ANZ J Surg; 2014 May 01; 84(1-2):52-8. PubMed ID: 23171083
    [Abstract] [Full Text] [Related]

  • 20. Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.
    Rubió-Casadevall J, Borràs JL, Carmona-García MC, Ameijide A, Gonzalez-Vidal A, Ortiz MR, Bosch R, Riu F, Parada D, Martí E, Miró J, Sirvent JJ, Galceran J, Marcos-Gragera R.
    World J Surg Oncol; 2015 Feb 13; 13():47. PubMed ID: 25885906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.